Medical Ikkou Group Co.,Ltd. (TYO:3353)
Japan flag Japan · Delayed Price · Currency is JPY
2,678.00
+13.00 (0.49%)
Nov 18, 2026, 9:14 AM JST

Medical Ikkou Group Financials Overview

Millions JPY. Fiscal year is Mar - Feb.

Revenue & Profits

Fiscal Year
TTMFY 2026FY 2025FY 2024FY 2023FY 2022
Period EndingAug '26 Feb '26 Feb '25 Feb '24 Feb '23 Feb '22
Revenue
56,30254,98248,39339,90033,89733,595
Revenue Growth
6.91%13.62%21.29%17.71%0.90%6.30%
Gross Profit
6,5986,4855,7444,5513,1823,613
Operating Income
1,8651,7881,6921,5599351,275
Net Income
1,4591,2751,1331,039759852
Earnings Per Share
387.43338.72301.31276.50202.04226.83
EPS Growth
33.72%12.41%8.97%36.85%-10.93%2.37%

Revenue by Segment

Fiscal Year
TTMFY 2026FY 2025FY 2024FY 2023FY 2022
Period EndingAug '26 Feb '26 Feb '25 Feb '24 Feb '23 Feb '22
Wholesale of Pharmaceuticals Business
21,59620,64116,1989,3103,9423,892
Healthcare Business
9,2958,9918,1227,7487,6727,814
Dispensing Pharmacy Business
26,45126,29124,71023,53723,09522,731
Unallocated Adjustment
-1,321-1,206-845.79-879.15-1,000-1,075
Real Estate Business
283.15265.28208.4185.64189.05233.2
Total
56,30354,98348,39339,90133,89833,596

Cash & Debt

Fiscal Year
CurrentFY 2026FY 2025FY 2024FY 2023FY 2022
Period EndingAug '26 Feb '26 Feb '25 Feb '24 Feb '23 Feb '22
Cash & Investments
7,5126,1216,7687,7006,4437,992
Total Debt
9,45810,36310,0169,5779,11511,311
Net Cash (Debt)
-1,946-4,242-3,248-1,877-2,672-3,319
Net Cash Growth
------
Net Cash Per Share
-516.75-1126.93-863.77-499.51-711.27-883.64

Cash Flow & CapEx

Fiscal Year
TTMFY 2026FY 2025FY 2024FY 2023FY 2022
Period EndingAug '26 Feb '26 Feb '25 Feb '24 Feb '23 Feb '22
Operating Cash Flow
2,1881,2081,1984,2771,3071,135
Capital Expenditures
-397-526-996-302-311-322
Free Cash Flow
1,7916822023,975996813
Free Cash Flow Growth
405.93%237.62%-94.92%299.10%22.51%-39.87%

Margins

Fiscal Year
TTMFY 2026FY 2025FY 2024FY 2023FY 2022
Period EndingAug '26 Feb '26 Feb '25 Feb '24 Feb '23 Feb '22
Gross Margin
11.72%11.79%11.87%11.41%9.39%10.76%
Operating Margin
3.31%3.25%3.50%3.91%2.76%3.79%
Pretax Margin
4.17%3.68%3.93%4.16%3.87%4.39%
Profit Margin
2.59%2.32%2.34%2.60%2.24%2.54%
FCF Margin
3.18%1.24%0.42%9.96%2.94%2.42%

Dividends

Fiscal Year
CurrentFY 2026FY 2025FY 2024FY 2023FY 2022
Period EndingNov '26 Feb '26 Feb '25 Feb '24 Feb '23 Feb '22
Dividend Per Share
120.000120.00060.00045.00040.00040.000
Dividend Per Share Growth
0%100.00%33.33%12.50%0%-50.00%
Dividend Yield
4.48%3.93%2.73%1.93%1.54%1.57%

Valuation

Fiscal Year
CurrentFY 2026FY 2025FY 2024FY 2023FY 2022
Period EndingNov '26 Feb '26 Feb '25 Feb '24 Feb '23 Feb '22
PE Ratio
6.919.017.308.4512.8211.24
P/FCF Ratio
5.6016.8440.972.219.7711.78
PS Ratio
0.180.210.170.220.290.28